TDOC — Teladoc Health, Inc.
NYSE
Q1 2026 Earnings Call Summary
April 30, 2026
TDOC Q1 2026 Earnings Call Summary
1. Key Financial Results and Metrics
- Consolidated Revenue: $614 million, exceeding guidance midpoint.
- Adjusted EBITDA: $58 million, representing a 9.5% margin.
- Net Loss per Share: $0.36, impacted by amortization, stock-based compensation, and restructuring costs.
- Free Cash Flow: Net outflow of $26 million; cash and cash equivalents at $751 million.
- Integrated Care Revenue: $395 million, a 1.5% year-over-year increase.
- BetterHelp Revenue: $218 million, down 9% year-over-year, with a decline in average paying users to 361,000.
2. Strategic Updates and Business Highlights
- Integrated Care Segment: Focus on scaling services and enhancing offerings, particularly in chronic care and mental health. The shift from subscription to visit-based models is seen as an opportunity for growth.
- BetterHelp: Successful rollout of insurance coverage, now live in 30 states with over 6,000 credentialed providers. Insurance revenue is projected to reach $125 million by year-end.
- AI Integration: Investments in AI and data infrastructure to improve service delivery and operational efficiency.
- Operational Efficiency: Emphasis on cost management and productivity initiatives across both segments.
3. Forward Guidance and Outlook
- 2026 Revenue Guidance: Expected to be between $2.48 billion and $2.58 billion, with adjusted EBITDA of $267 million to $306 million.
- Q2 2026 Guidance: Revenue expected between $597 million and $626 million, with adjusted EBITDA between $55 million and $67 million.
- Integrated Care: Anticipated growth in the second half of 2026, driven by contract implementations and enhanced visit revenue.
- BetterHelp: Revenue expected to decline between 6.5% and 1% year-over-year, with insurance revenue projected at $90 million to $105 million.
4. Bad News, Challenges, or Points of Concern
- BetterHelp Performance: Continued pressure on the direct-to-consumer cash pay business, leading to a decline in average paying users and overall revenue.
- Market Dynamics: The shift from subscription to visit-based models has created near-term revenue headwinds, although it is expected to become a tailwind by the end of 2026.
- Implementation Delays: Some contract implementations have been pushed to the second half of 2026 due to client-driven timing issues.
- Competitive Pressures: The chronic care market remains crowded with many point solutions, leading to potential challenges in differentiation.
5. Notable Q&A Insights
- Integrated Care Growth: Management expressed confidence in returning to growth, citing the shift to visit-based arrangements and new product innovations.
- BetterHelp Insurance Rollout: The insurance strategy is showing positive results, with higher session engagement among insured users compared to cash pay users.
- Therapist Capacity: Building therapist capacity remains a challenge, but management is optimistic about scaling the insurance-focused offering.
- Market Stabilization: Early signs of stabilization in the BetterHelp business were noted, particularly in states where insurance has been implemented for longer periods.
- CFO Search: The search for a new CFO is ongoing, with a focus on finding a candidate that fits well with the organization and can drive financial performance.
Overall, while Teladoc Health is navigating challenges in its BetterHelp segment and the transition to visit-based revenue models, there are positive indicators of growth and strategic initiatives that could enhance its market position moving forward.
